Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

BACKGROUND: Activation of inflammatory pathways plays an important contributory role in coronary plaque instability and subsequent rupture, which can lead to the development of acute coronary syndrome (ACS). Elevated levels of serum inflammatory markers such as C-reactive protein (CRP) represent ind...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Control Trials Cardiovasc Med
Main Authors: Ostadal, Petr, Alan, David, Hajek, Petr, Vejvoda, Jiri, Mates, Martin, Blasko, Peter, Veselka, Josef, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Nemecek, Eduard, Holm, Frantisek, Rac, Marek, Macek, Milan, Cepova, Jana
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2005
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC555952/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15790413/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1468-6708-6-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados